Literature DB >> 5066903

Iatrogenic maternal hypocalcemia following magnesium sulfate therapy.

G R Monif, J Savory.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5066903

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Effects of the intravenous administration of magnesium sulfate on corrected serum calcium level and nephrogenous cyclic AMP excretion in normal human subjects.

Authors:  K Suzuki; K Nonaka; N Kono; K Ichihara; Y Fukumoto; Y Inui; J Miyagawa; T Onishi; C Hayashi; S Tarui
Journal:  Calcif Tissue Int       Date:  1986-11       Impact factor: 4.333

Review 2.  Magnesium sulfate in eclampsia and pre-eclampsia: pharmacokinetic principles.

Authors:  J F Lu; C H Nightingale
Journal:  Clin Pharmacokinet       Date:  2000-04       Impact factor: 6.447

Review 3.  Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review.

Authors:  Emily S Bain; Philippa F Middleton; Caroline A Crowther
Journal:  BMC Pregnancy Childbirth       Date:  2013-10-21       Impact factor: 3.007

4.  Hypocalcemia and hyperkalemia during magnesium infusion therapy in a pre-eclamptic patient.

Authors:  Tamer Hudali; Chandandeep Takkar
Journal:  Clin Case Rep       Date:  2015-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.